DSRLF

Healthcare Diagnostics & Research

DiaSorin S.p.A.

$84.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

4.15B

Avg Volume

102

P/E (TTM)

26.50

EPS

$3.17

52W High

$94.25

52W Low

$66.50

Div. Yield

1.5%

Valuation

P/B Ratio

2.59

P/S Ratio

3.53

EV/EBITDA

14.61

EV/Revenue

4.24

PEG Ratio

1.57

Margins

Gross Margin 64.5%

Operating Margin 22.4%

Net Margin 11.9%

EBITDA Margin 29.0%

Growth & Returns

Revenue Growth (YoY)

2.7%

Earnings Growth (YoY)

6.6%

Earnings Growth (QoQ)

(2.2%)

Return on Equity

9.2%

Return on Assets

5.5%

Liquidity & Leverage

Current Ratio

1.79

Quick Ratio

0.85

Debt / Equity

0.68

Total Cash

120.88M

Total Debt

965.25M

About

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.

int.diasorin.com